October, 2025
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
FDA Expands Repatha (Evolocumab) Approval: New Options for Adults With Uncontrolled LDL-C and HoFH
Aug 26, 2025, 09:45

FDA Expands Repatha (Evolocumab) Approval: New Options for Adults With Uncontrolled LDL-C and HoFH

 

 Family Heart Foundation posted on X:

”FDA expands approval of Repatha® (evolocumab) for adults at risk of CV events from uncontrolled LDL-C—even without established CVD. Now approved as monotherapy for HoFH. Important update for clinicians   managing FH patients.”

Find more information here.

 

Stay updated with Hemostasis Today.